Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Maybe they can't announce anything until

Well, you thought incorrectly. I considered a combo PR, but as I've posted, the '336 decision is likely a little ways off at best from being posted on the transaction history, and even then, the OFFICIAL publication of the '336 if it does get recertified is over three months away. So, to delay this announcement to then, would seem impractical at best, and at worse, reinforces the point I make that you take issue with.

As for the "worth" of the patents, the ONLY worth that is of consequence to ME, an investor in PTSC, is how it is reflected in the shareprice. Clearly, to date, there is little reflection of increased worth of the '584, recertified or otherwise, and as reinforced by the lack of licensing activity recently. Whether an EE on a message board states otherwise, is an interesting perspective to rely on, as the language in the amended patent has been available to the PERTINENT EE's that MATTER in determining the WORTH of the patent for sometime, and to date doesn't seem to have effected any change. So, from that perspective, a PUBLIC annnouncement by the COMPANY, will, IMO, prove the worth of the recertified '584 far more accurately than your EE's review. Wouldn't you agree?

Share
New Message
Please login to post a reply